SCHEMBL9688675

SCHEMBL9688675

CCCN(CCC)CCc1ccc([N+](=O)[O-])c2[nH]ncc12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOS1 P29475 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
CYP1A2 P05177 2/20 0.41
HSD17B10 Q99714 2/20 0.41
KDM4E B2RXH2 1/20 0.41
MEN1 O00255 1/20 0.41
CYP3A4 P08684 1/20 0.41
MAPT P10636 1/20 0.41
THRB P10828 1/20 0.41
HPGD P15428 1/20 0.41
TSHR P16473 1/20 0.41
APEX1 P27695 1/20 0.41
NOS3 P29474 1/20 0.41
CYP2C19 P33261 1/20 0.41
NOS2 P35228 1/20 0.41
RECQL P46063 1/20 0.41
BLM P54132 1/20 0.41
KMT2A Q03164 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
TDP1 Q9NUW8 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9688419 0.86 SMN1; SMN2 (0.43) NOS1SMN1; SMN2CYP1A2HSD17B10KDM4E
SCHEMBL9689265 0.78 HTR1A (0.48) CYP1A2HSD17B10KDM4ECYP3A4TSHR
SCHEMBL9687746 0.78 HTR1A (0.38) CYP1A2HSD17B10KDM4ECYP3A4THRB
SCHEMBL9687961 0.76 HPGD (0.48) NOS1SMN1; SMN2CYP1A2HSD17B10KDM4E
SCHEMBL9689086 0.74 NOS1 (0.42) NOS1SMN1; SMN2CYP1A2HSD17B10KDM4E
SCHEMBL9689089 0.74 NOS1 (0.42) NOS1SMN1; SMN2CYP1A2HSD17B10KDM4E
SCHEMBL11606284 0.73 MAPT (0.59) NOS1SMN1; SMN2CYP1A2HSD17B10KDM4E
SCHEMBL9689065 0.71 MAPT (0.53) NOS1SMN1; SMN2CYP1A2HSD17B10KDM4E
SCHEMBL23275822 0.68 NOS1 (0.53) NOS1SMN1; SMN2CYP1A2HSD17B10KDM4E
SCHEMBL28673208 0.68 MAPT (0.53) NOS1SMN1; SMN2CYP1A2HSD17B10KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0189473-B1 NEW DOPAMINE DERIVATIVES, PROCESS FOR THEIR PRODUCTION, AND THEIR USE AS MEDICINAL PRODUCTS SCHERING AKTIENGESELLSCHAFT (DE) 1992-05-27 EP disclosed
US-4958026-A HYPOTENSIVE AGENTS SCHERING AKTIENGESLLSCHAFT (DE) 1990-09-18 US disclosed
EP-0189473-A1 NEW DOPAMINE DERIVATIVES, PROCESS FOR THEIR PRODUCTION, AND THEIR USE AS MEDICINAL PRODUCTS. SCHERING AG (DE) 1986-08-06 EP disclosed
WO-1986001204-A1 NEW DOPAMINE DERIVATIVES, PROCESS FOR THEIR PRODUCTION, AND THEIR USE AS MEDICINAL PRODUCTS SCHERING AKTIENGESELLSCHAFT (DE) 1986-02-27 WO disclosed